Viewing Study NCT06755450

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 5:08 PM
Ignite Modification Date: 2026-01-23 @ 5:17 PM
Study NCT ID: NCT06755450
Status: RECRUITING
Last Update Posted: 2025-08-26
First Post: 2024-12-31
Is Gene Therapy: True
Has Adverse Events: False
Brief Title: Study Evaluating Safety Pharmacokinetics and Pharmacodynamics of AUR112 in Patients With Relapsed Advanced Lymphoma
Sponsor: Aurigene Discovery Technologies Limited
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Relapsed Advanced Lymphomas View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Non-Hodgkin Lymphoma (NHL) View
None Hodgkin Lymphoma View
None Relapse Advanced Lymphomas View